Literature DB >> 11351337

N-cadherin is regulated by gonadal steroids in adult sexually dimorphic spinal motoneurons.

D A Monks1, S Getsios, C D MacCalman, N V Watson.   

Abstract

Gonadal steroids influence the morphology and function of neurons in the adult spinal cord through cellular and molecular mechanisms that are largely unknown. The cadherins are cell adhesion molecules that participate in the formation and organization of the CNS during embryonic development, and recent evidence suggests that the cadherins continue to regulate neural structure and function in adulthood. Using degenerate oligonucleotides coding conserved regions of the catenin-binding domain of classical cadherins in a RT-PCR cloning strategy, we identified several cadherin subtypes, the most frequently cloned being N-, E-, and R-cadherin, suggesting that these are the major classical cadherin subtypes present in the adult male rat lumbosacral spinal cord. We then examined cadherin expression levels of these cadherin subtypes under steroid conditions known to induce plastic changes in spinal motoneurons. Semiquantitative PCR revealed that mRNA levels of N-cadherin, but not E-cadherin or R-cadherin, are elevated in castrated rats treated with testosterone, 17 beta-estradiol, or dihydrotestosterone relative to castrate rats not treated with steroids. Immunolocalization of N-cadherin revealed that steroid treatment increased N-cadherin expression levels in functionally related neural populations whose morphology and function are regulated by steroids. These results suggest a role for N-cadherin in steroid-induced neuroplastic change in the adult lumbar spinal cord. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11351337     DOI: 10.1002/neu.1033

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  9 in total

Review 1.  The spinal nucleus of the bulbocavernosus: firsts in androgen-dependent neural sex differences.

Authors:  Dale R Sengelaub; Nancy G Forger
Journal:  Horm Behav       Date:  2007-11-28       Impact factor: 3.587

Review 2.  Regulation of cadherin expression in nervous system development.

Authors:  Alicia F Paulson; Maneeshi S Prasad; Amanda Henke Thuringer; Pasquale Manzerra
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

3.  Myocyte androgen receptors increase metabolic rate and improve body composition by reducing fat mass.

Authors:  Shannon M Fernando; Pengcheng Rao; Lee Niel; Diptendu Chatterjee; Marijana Stagljar; D Ashley Monks
Journal:  Endocrinology       Date:  2010-04-28       Impact factor: 4.736

4.  Trophic effects of brain-derived neurotrophic factor blockade in an androgen-sensitive neuromuscular system.

Authors:  Tom Verhovshek; Dale R Sengelaub
Journal:  Endocrinology       Date:  2010-09-22       Impact factor: 4.736

5.  Testosterone metabolites differentially maintain adult morphology in a sexually dimorphic neuromuscular system.

Authors:  Tom Verhovshek; Katherine E Buckley; Melissa A Sergent; Dale R Sengelaub
Journal:  Dev Neurobiol       Date:  2010-03       Impact factor: 3.964

Review 6.  Neuroprotective actions of androgens on motoneurons.

Authors:  Keith N Fargo; Eileen M Foecking; Kathryn J Jones; Dale R Sengelaub
Journal:  Front Neuroendocrinol       Date:  2009-04-23       Impact factor: 8.606

7.  Androgenic, but not estrogenic, protection of motoneurons from somal and dendritic atrophy induced by the death of neighboring motoneurons.

Authors:  Keith N Fargo; Dale R Sengelaub
Journal:  Dev Neurobiol       Date:  2007-07       Impact factor: 3.964

Review 8.  Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy.

Authors:  Douglas Ashley Monks; Pengcheng Rao; Kaiguo Mo; Jamie Ann Johansen; Gareth Lewis; Michael Quentin Kemp
Journal:  Horm Behav       Date:  2008-01-05       Impact factor: 3.587

Review 9.  Androgen Effects on Neural Plasticity.

Authors:  Nariko Kuwahara; Kate Nicholson; Lauren Isaacs; Neil J MacLusky
Journal:  Androg Clin Res Ther       Date:  2021-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.